ARS Pharmaceuticals
SPRY
#4946
Rank
NZ$2.24 B
Marketcap
$22.87
Share price
-4.48%
Change (1 day)
44.65%
Change (1 year)

ARS Pharmaceuticals (SPRY) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.56 Billion

According to ARS Pharmaceuticals's latest financial reports the company has NZ$0.56 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ARS Pharmaceuticals - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.55 B54.2%
2023-12-31NZ$0.36 B-16.44%
2022-12-31NZ$0.43 B391.46%
2021-12-31NZ$87.93 M158.75%
2020-12-31NZ$33.98 M